Members of the audience at the EHA patient advocacy session on ‘access to clinical trials’ question the panellists representing patients, clinicians or industry on the issues that have been raised. These issues include the ethics of clinical trials, the influence of conflicts of interests, the role patient advocacy groups can play in trial design and the lack of a standardised test for the BCRA mutation.